EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter

Nora-Fabienne Paul, Karolin Gustmann, Jens Tetens, Clemens Falker-Gieske

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09726-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Nora-Fabienne Paul und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany. Hauptthemen laut MEDLINE: Leupeptins, Chickens, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Georg-August-Universität Göttingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MG132, a proteasome inhibitor, is widely used to inhibit nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activity by proteasome-mediated degradation of IκB. It has been marketed as a specific, reversible, cell-permeable and low-cost inhibitor. However, adverse effects of the compound have been reported in the literature. We recently discovered and characterised a point mutation in the acute phase protein serum amyloid A (SAA) in chickens, by overexpressing the protein in chicken hepatocellular carcinoma (LMH) cells. This serine to arginine exchange at amino acid position 90 (SAA.R90S) leads to intra- and extracellular accumulation of SAA, which is surprisingly counteracted by MG132 treatment, independent of SAA ’s intrinsic promoter. Methods and Results To test, whether low proteasomal degradation of SAA.R90S is responsible for the observed intra- and extracellular SAA accumulation, we intended to inhibit the proteasome in SAA wild type (SAA.WT) overexpressing cells with MG132. However, we observed an unexpected drastic decrease in SAA protein expression at the transcript level. NF-κB gene expression was unchanged by MG132 at the measured time point.

Conclusions

The observed results demonstrate that MG132 inhibits SAA expression at the transcript level, independent of its endogenous promoter. Further, the data might indicate that NF-κB is not involved in the observed MG132-induced inhibition of SAA expression. We, consequently, question in this brief report whether MG132 should truly be categorised as a specific ubiquitin proteasome inhibitor and recommend the usage of alternative compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeupeptinsChickensCarcinoma, HepatocellularLiver NeoplasmsPromoter Regions, GeneticSerum Amyloid A ProteinNF-kappa BAnimalsCell Line, TumorProteasome Endopeptidase ComplexProteasome InhibitorsGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

MG132NF-κBSAASerum amyloid A

Substanzen

benzyloxycarbonylleucyl-leucyl-leucine aldehydeLeupeptinsSerum Amyloid A ProteinNF-kappa BProteasome Endopeptidase ComplexProteasome Inhibitors

Autor:innen und Institutionen

  • Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany.
  • Center for Integrated Breeding Research, Georg-August-University, Albrecht-Thaer-Weg 3, 37075, Göttingen, Germany.
  • Department of Animal Sciences, Division of Functional Breeding, Georg-August-Universität Göttingen, Burckhardtweg 2, 37077, Göttingen, Germany. clemens.falker-gieske@uni-goettingen.de.
  • Center for Integrated Breeding Research, Georg-August-University, Albrecht-Thaer-Weg 3, 37075, Göttingen, Germany. clemens.falker-gieske@uni-goettingen.de.

Förderung

  • Georg-August-Universität Göttingen

Zitieren

APA

Paul, N. F., Gustmann, K., Tetens, J., & Falker-Gieske, C. (2024). MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09726-9

Vancouver

Paul NF, Gustmann K, Tetens J, Falker-Gieske C. MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09726-9

BibTeX
@article{Paul2024,
  author = {Paul, Nora-Fabienne and Gustmann, Karolin and Tetens, Jens and Falker-Gieske, Clemens},
  title = {MG132 dramatically reduces SAA expression in chicken hepatocellular carcinoma cells at the transcript level independent of its endogenous promoter},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09726-9}
}
Kostenlos starten →